ConductScience.org, home

Paper24673373

Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery.

Fang RH and 7 others. Nano Lett, 2014. Cited by 1,120 papers, by iCite.

Cite this record

ConductScience Library. Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Papers, record 24673373. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24673373

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery.
PubMed
Journal
Nano Lett
PubMed
Year
2014
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
1,120
iCite
Relative citation ratio, by iCite
33.5
iCite
Revised in PubMed
2021-10-21
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fang RHRonnie H
2Hu CMChe-Ming J
3Luk BTBrian T
4Gao WWeiwei
5Copp JAJonathan A
6Tai YYiyin
7O'Connor DEDerek E
8Zhang LLiangfang

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, NeoplasmMajor topic
Cancer VaccinesMajor topic
Cell MembraneMajor topic
Drug Delivery SystemsMajor topic
NanoparticlesMajor topic
NeoplasmsMajor topic
Animals
Cell Line, Tumor
Humans
Immunotherapy
Mice, Inbred C57BL
Nanomedicine

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R25CA153915NCI NIH HHSUnited StatesR25CA153915PubMedNIH RePORTER
R01 DK095168NIDDK NIH HHSUnited StatesR01DK095168PubMed and NIHNIH RePORTER
R01DK095168NIDDK NIH HHSUnited StatesR01DK095168PubMed and NIHNIH RePORTER
P30 CA023100NCI NIH HHSUnited StatesP30CA023100PubMed and NIHNIH RePORTER
R25 CA153915NCI NIH HHSUnited StatesR25CA153915PubMedNIH RePORTER

Download CSV of grants

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118654426Nanocarriers as an emerging platform for cancer therapy.Nat Nanotechnol2007https://conductscience.org/library/papers/18654426PubMed
217981204Regulation of interferon-gamma during innate and adaptive immune responses.Adv Immunol2007https://conductscience.org/library/papers/17981204PubMed
312839977Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium.Cancer Res2003https://conductscience.org/library/papers/12839977PubMed
417873867Exploiting lymphatic transport and complement activation in nanoparticle vaccines.Nat Biotechnol2007https://conductscience.org/library/papers/17873867PubMed
517569868The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4.Science2007https://conductscience.org/library/papers/17569868PubMed
622332936Nanoparticles disguised as red blood cells to evade the immune system.Expert Opin Biol Ther2012https://conductscience.org/library/papers/22332936PubMed
716651452Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors.Cancer Res2006https://conductscience.org/library/papers/16651452PubMed
823786263Reconstructed stem cell nanoghosts: a natural tumor targeting platform.Nano Lett2013https://conductscience.org/library/papers/23786263PubMed
917558426The perfect mix: recent progress in adjuvant research.Nat Rev Microbiol2007https://conductscience.org/library/papers/17558426PubMed
1024280870Polymeric nanotherapeutics: clinical development and advances in stealth functionalization strategies.Nanoscale2014https://conductscience.org/library/papers/24280870PubMed
1118697944The effect of particle design on cellular internalization pathways.Proc Natl Acad Sci U S A2008https://conductscience.org/library/papers/18697944PubMed
1223184788Erythrocyte-inspired delivery systems.Adv Healthc Mater2012https://conductscience.org/library/papers/23184788PubMed
1310856220Role of CD47 as a marker of self on red blood cells.Science2000https://conductscience.org/library/papers/10856220PubMed
148400144Adhesion molecules in tumor metastasis.Semin Cancer Biol1993https://conductscience.org/library/papers/8400144PubMed
1512438311MDA-MB-435 human breast carcinoma cell homo- and heterotypic adhesion under flow conditions is mediated in part by Thomsen-Friedenreich antigen-galectin-3 interactions.J Biol Chem2003https://conductscience.org/library/papers/12438311PubMed
1622899335Preparation of multifunctional nanoparticles and their assemblies.Nat Protoc2012https://conductscience.org/library/papers/22899335PubMed
1722641380Engineering nano- and microparticles to tune immunity.Adv Mater2012https://conductscience.org/library/papers/22641380PubMed
1821631324gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma.N Engl J Med2011https://conductscience.org/library/papers/21631324PubMed
1919721436Rethinking therapeutic cancer vaccines.Nat Rev Drug Discov2009https://conductscience.org/library/papers/19721436PubMed
208349740Homophilic adhesion between Ig superfamily carcinoembryonic antigen molecules involves double reciprocal bonds.J Cell Biol1993https://conductscience.org/library/papers/8349740PubMed

See all 50 referencesDownload CSV of references

Cited by589

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,120 citations.

PMIDTitleJournalYearIn PapersSource
42943937Construction and Functional Engineering of Bio-Integrated Micro/Nanorobots for Theranostic Applications.Micromachines (Basel)2026https://conductscience.org/library/papers/42943937PubMed
42942844Cell Membrane-Coated Nanoparticles as Biomimetic Drug Delivery Systems: Design, Therapeutic Applications, and Translational Challenges.Pharmaceutics2026https://conductscience.org/library/papers/42942844PubMed
42892943EGFR-antibody-decorated cancer-cell-membrane-coated MOF nanoplatform enables targeted delivery of the STING agonist diABZI for pancreatic cancer immunotherapy.Int J Pharm X2026https://conductscience.org/library/papers/42892943PubMed
42856429Single-Particle STORM Imaging Quantifies Coating Heterogeneity Among Cell Membrane-Coated Nanoparticles.bioRxiv2026https://conductscience.org/library/papers/42856429PubMed
42851668A Trojan horse nanoplatform overcoming delivery barriers for targeted gene immunotherapy of colorectal cancer.Front Bioeng Biotechnol2026https://conductscience.org/library/papers/42851668PubMed
42822783In Vitro Investigation of LIFU-Triggered, Visualizable Bionic Nanoparticles for a "Three-In-One" Therapy Against Medullary Thyroid Carcinoma.Technol Cancer Res Treat2026https://conductscience.org/library/papers/42822783PubMed
42816842Tumor cell membrane‑coated MOF‑199 nanoparticles co‑loaded with auranofin and celecoxib enhance single‑dose radiotherapy and anti‑PD‑L1 therapy in cervical cancer.J Nanobiotechnology2026https://conductscience.org/library/papers/42816842PubMed
42811335Targeting cancer-associated fibroblasts: therapeutic strategies, translational challenges, and future perspectives.J Hematol Oncol2026https://conductscience.org/library/papers/42811335PubMed
42797238Layer by Layer Engineered Lipid-Based Nanocarriers for Therapeutic Delivery and Next-Generation Design.Pharmaceutics2026https://conductscience.org/library/papers/42797238PubMed
42781594Bioinspired and Biomimetic Nanocarriers: Advances in Exosomes and Cell-Membrane-Coated Systems for Therapeutic Applications.Int J Nanomedicine2026https://conductscience.org/library/papers/42781594PubMed
42771161Smart drug delivery systems for immunotherapeutic agents: focus on biological/biogenic platform-based intelligent delivery in cancer immunotherapy.Drug Deliv Transl Res2026https://conductscience.org/library/papers/42771161PubMed
42730348Micro/Nanorobots (MNRs) at the Intersection of Mechanobiology and Artificial Intelligence: An Emerging Frontier for Precision Nanomedicine.ACS Nano Med2026https://conductscience.org/library/papers/42730348PubMed
42719493Photodynamically Sensitized Mitochondrial-Damage Amplification Strategy Promotes Pyroptosis-Induced Immunotherapy of Osteosarcoma.Biomater Res2026https://conductscience.org/library/papers/42719493PubMed
42719113Advances in nanomaterial-based delivery systems for inducing transplantation tolerance.Front Immunol2026https://conductscience.org/library/papers/42719113PubMed
42715057Biomimetic Virus-Like Mesoporous Silica Nanoparticles Activate NK Cells Indirectly via Monocyte Crosstalk.Nano Lett2026https://conductscience.org/library/papers/42715057PubMed
42709284Nanomedicine beyond carriers - devices, cells & living therapeutics.Biomed Microdevices2026https://conductscience.org/library/papers/42709284PubMed
42670442Theragenerative Nanomaterials: Integrating Therapy, Regeneration, and Diagnosis-Navigating the Shared Pathways Between Tissue Repair and Malignancy.Int J Nanomedicine2026https://conductscience.org/library/papers/42670442PubMed
42639936From Cell-Derived Vesicles to Hybrid Nanovectors: Biological Membranes as Functional Blueprints for Gene Delivery.Adv Healthc Mater2026https://conductscience.org/library/papers/42639936PubMed
42605503Precisely Engineering Biomimetic Nanoparticles via Controlled Cell Membrane Coating.Small2026https://conductscience.org/library/papers/42605503PubMed
42590834Targeted delivery of mRNA to immune cells for in vivo cell therapy.Drug Deliv2026https://conductscience.org/library/papers/42590834PubMed

See all 589 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24673373

GET https://conductscience.org/api/papers/v1/24673373/references?page=2